General Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Handheld Devices, Laparoscopic Devices, Electrosurgical Devices, Medical Robotics & Computer-Assisted Surgical Devices, Others), By Methods (Open Surgery and Minimally Invasive Surgery), By Application (Gynecology, Urology, Cardiology, Orthopedic, Neurology, Others), By End User (Hospital & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F

Market Overview

The Global General Surgery Devices Market, valued at USD 17.10 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 28.54 Billion by 2030. The Global General Surgery Devices Market comprises medical instruments, equipment, and tools utilized by surgeons across a broad spectrum of procedures, enabling precise incisions, tissue manipulation, suturing, and wound closure in both open and minimally invasive settings. Market growth is primarily supported by a globally aging population and the escalating prevalence of chronic diseases necessitating surgical interventions. Additionally, advancements in surgical techniques, including the increasing adoption of minimally invasive and robotic-assisted procedures, significantly contribute to market expansion, alongside enhanced healthcare infrastructure in emerging economies.

Despite these market drivers, a significant challenge impeding expansion is the substantial cost associated with general surgical devices. According to the American College of Surgeons, in 2024, 4.1 million people in 166 countries received Stop the Bleed training, with 1 million trained in that year alone, indicating widespread engagement in surgical readiness initiatives. The high acquisition and maintenance expenses of advanced surgical technologies, coupled with reimbursement complexities, can restrict access and uptake, particularly in cost-sensitive markets.

Key Market Drivers

Technological advancements in surgical devices significantly influence the Global General Surgery Devices Market by introducing tools that enhance precision, diminish invasiveness, and improve patient outcomes. Innovations span advanced visualization systems, robotics, and integrated navigation platforms, facilitating complex procedures with heightened efficiency and enabling novel surgical approaches. According to OrthoFeed, in April 2025, Pixee Medical announced FDA 510(k) clearance of Knee+ NexSight, an Augmented Reality guidance solution for total knee arthroplasty, specifically targeting the expanding needs of ambulatory surgical centers. These developments drive the adoption of sophisticated instruments, expanding the market by offering superior alternatives.

The rising global burden of chronic diseases serves as another primary driver for the general surgery devices market, creating an escalating demand for surgical interventions. Conditions like cardiovascular diseases, cancer, and diabetes frequently necessitate surgical management, from diagnostic biopsies to complex therapeutic operations. This demographic reality directly translates into increased procedural volumes requiring a diverse array of surgical instruments. According to a study published in The Lancet, in June 2024, the global diabetes prevalence is estimated to reach approximately 1.31 billion individuals in 2025, signifying a substantial population in need of potential surgical care for complications. This persistent demand is further reflected in industry performance; according to Johnson & Johnson's Q3 2025 results, reported in October 2025, their MedTech operational sales grew 5.6%, partly driven by wound closure products in General Surgery.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with general surgical devices presents a significant challenge to the Global General Surgery Devices Market. High acquisition and maintenance expenses for advanced surgical technologies, coupled with complexities in reimbursement, directly restrict access and uptake. This financial burden often limits healthcare providers' capacity to invest in new equipment, particularly within cost-sensitive healthcare systems and emerging economies, thereby impeding market expansion.

This challenge is evident in recent expenditures and investment trends. According to the American Hospital Association, medical supply expenses in the United States collectively reached $146.9 billion in 2023, marking an increase of $6.6 billion over 2022. Such considerable operating costs compel healthcare institutions to defer critical capital investments. Illustrating this, the average age of capital investments for medical equipment and infrastructure across all hospitals increased by 7.1% in 2023. This trend of delayed equipment replacement directly hinders the adoption of newer, advanced general surgery devices, consequently slowing the overall growth of the market.

Key Market Trends

Two significant trends currently shaping the Global General Surgery Devices Market are the expansion of ambulatory surgical centers and outpatient settings, alongside the increasing preference for disposable surgical supplies. These trends represent shifts in healthcare delivery models and operational priorities, distinct from core technological advancements or disease burden drivers.

The expansion of ambulatory surgical centers (ASCs) and outpatient settings is profoundly influencing the market by moving surgical procedures from costly inpatient hospital environments to more efficient, patient-centric facilities. This shift is driven by lower operational costs, improved patient convenience, and shorter recovery times for suitable procedures. According to the Ambulatory Surgery Center Association (ASCA), in December 2023, the median number of patient encounters per year in participating ASCs increased to 4,000 from 3,483 in 2021, demonstrating a notable rise in procedural volume within these settings. This trend necessitates a diverse range of general surgery devices optimized for efficiency and rapid turnover. Healthcare systems are actively investing in this area; according to Becker's ASC, in October 2024, HCA Healthcare planned to add 100 outpatient facilities by the end of 2024, increasing its total sites of care to over 2,600, signaling a sustained strategic focus on outpatient growth.

A growing preference for disposable surgical supplies is also a pivotal trend, largely driven by heightened concerns over infection control and the desire for streamlined operational workflows. Single-use instruments eliminate the need for complex and costly reprocessing, thereby reducing the risk of healthcare-associated infections and enhancing patient safety. This trend is impacting procurement patterns in general surgery. Reflecting this demand, Intuitive Surgical, a key player in surgical systems, reported in January 2025 that its preliminary full year 2024 instruments and accessories revenue increased by 19% to approximately $5.08 billion, primarily driven by growth in da Vinci and Ion procedure volume and customer buying patterns. The consistent availability of sterile, ready-to-use disposable instruments also contributes to greater surgical efficiency and predictable performance in various general surgery procedures.

Segmental Insights

Within the Global General Surgery Devices Market, the Laparoscopic Devices segment is experiencing the most rapid expansion. This accelerated growth is primarily attributed to the increasing adoption of minimally invasive surgical techniques, which offer significant patient benefits over traditional open surgeries. These advantages include reduced postoperative pain, smaller incisions, quicker recovery times, and shorter hospital stays, leading to improved patient outcomes and satisfaction. Furthermore, ongoing technological advancements in imaging systems and instrumentation enhance surgical precision, while the rising global incidence of chronic conditions requiring surgical intervention further drives demand for laparoscopic procedures.

Regional Insights

North America leads the global general surgery devices market due to its highly developed healthcare infrastructure and significant healthcare expenditure. The region benefits from a robust presence of major medical device manufacturers, fostering innovation and the early adoption of advanced surgical technologies, including minimally invasive and robotic-assisted techniques. Furthermore, favorable reimbursement policies and stringent regulatory oversight by bodies such as the U. S. Food and Drug Administration (FDA) ensure product safety and efficacy, instilling confidence and facilitating market growth. This combination of advanced facilities, technological leadership, and a supportive regulatory and reimbursement environment underpins North America's market dominance.

Recent Developments

• In October 2025, Medtronic initiated a U.S. Investigational Device Exemption (IDE) clinical study, named "Embrace Gynecology," to evaluate the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures. This undertaking represents a significant step towards broadening access to minimally invasive treatment options for women. The Hugo RAS system is integral to Medtronic’s commitment to clinical innovation in robotic surgery, with the company aiming to secure additional indications for its advanced general surgery device platform in the United States.

• In October 2025, Intuitive announced that the U.S. Food & Drug Administration (FDA) granted clearance for software enhancements to its Ion endoluminal system. This robotic-assisted bronchoscopy platform, specifically designed for lung biopsies, now incorporates artificial intelligence (AI) to improve navigational accuracy. The advancements aim to address technical challenges, such as CT-to-body divergence, which can complicate the precise targeting of lung nodules. This breakthrough research and product improvement by Intuitive directly contributes to enhancing precision and efficiency in diagnostic procedures within the Global General Surgery Devices Market.

• In April 2025, Johnson & Johnson MedTech completed the initial clinical cases involving its OTTAVA Robotic Surgical System. This multi-specialty soft-tissue surgical robot is engineered to support a range of general surgery procedures, particularly those within the upper abdomen. This achievement followed the system's Investigational Device Exemption (IDE) approval from the U.S. FDA in late 2024, signifying substantial progress in advancing robotic-assisted surgery within the Global General Surgery Devices Market. The company intends to pursue De Novo authorization upon the study's conclusion.

• In January 2025, Intuitive Surgical announced plans for the full-scale market launch of its da Vinci 5 surgical system during the middle of the year. This advanced robotic system had commenced a limited rollout in March 2024, during which over 360 systems were placed, facilitating more than 32,000 procedures. The expanded availability of the da Vinci 5 system is expected to further drive the adoption of robotic-assisted, minimally invasive procedures across various general surgery applications globally, enhancing surgical precision and patient outcomes.

Key Market Players

• Braun Melsungen AG
• Johnson & Johnson
• Medtronic Plc
• Becton, Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• Conmed Corporation
• Cadence Inc.
• Erbe Elektromedizin GmbH
• CoreLink, LLC

Report Scope:

In this report, the Global General Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• General Surgery Devices Market, By Product Type:

o   Handheld Devices

o   Laparoscopic Devices

o   Electrosurgical Devices

o   Medical Robotics & Computer-Assisted Surgical Devices

o   Others

• General Surgery Devices Market, By Methods:

o   Open Surgery

o   Minimally Invasive Surgery

• General Surgery Devices Market, By Application:

o   Gynecology

o   Urology

o   Cardiology

o   Orthopedic

o   Neurology

o   Others

• General Surgery Devices Market, By End User:

o   Hospital & Clinics

o   Ambulatory Surgical Centers

o   Others

• General Surgery Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global General Surgery Devices Market.

Available Customizations:

Global General Surgery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global General Surgery Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]